168 related articles for article (PubMed ID: 38254953)
21. SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients.
Liu F; Deng S; Li Y; Du J; Zeng H
Front Genet; 2022; 13():1081262. PubMed ID: 36685828
[No Abstract] [Full Text] [Related]
22. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
[TBL] [Abstract][Full Text] [Related]
23. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia.
Song Y; Tian S; Zhang P; Zhang N; Shen Y; Deng J
Front Genet; 2021; 12():708699. PubMed ID: 35111195
[TBL] [Abstract][Full Text] [Related]
24. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
25. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
26. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
28. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
Fu D; Zhang B; Wu S; Feng J; Jiang H
Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
[TBL] [Abstract][Full Text] [Related]
29. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
30. Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia.
Pan M; Zhou J; Jiao C; Ge J
Hematology; 2023 Dec; 28(1):2221101. PubMed ID: 37294065
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification.
Zhao Y; Niu LT; Hu LJ; Lv M
Front Oncol; 2022; 12():947492. PubMed ID: 36172164
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Shi M; Xu G
BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes.
Ke P; Zhu Q; Xu T; Yang X; Wang Y; Qiu H; Wu D; Bao X; Chen S
Aging (Albany NY); 2023 Jun; 15(12):5826-5853. PubMed ID: 37367950
[TBL] [Abstract][Full Text] [Related]
34. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract][Full Text] [Related]
35. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
[TBL] [Abstract][Full Text] [Related]
36. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes.
Wang Y; Bin T; Tang J; Xu XJ; Lin C; Lu B; Sun TT
Front Immunol; 2023; 14():1268090. PubMed ID: 38077322
[TBL] [Abstract][Full Text] [Related]
37. A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia.
Wu F; Xu G; Li G; Yin Z; Shen H; Ye K; Zhu Y; Zhang Q; Ou R; Liu S
Front Mol Biosci; 2023; 10():1281141. PubMed ID: 38161382
[No Abstract] [Full Text] [Related]
38. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
39. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract][Full Text] [Related]
40. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
